We also calculated 1 valuable employee in our database.
Deals in the range of more than 100 millions dollars are the general things for fund. The fund is generally included in 2-6 deals every year. The important activity for fund was in 2018. Comparing to the other companies, this King Star Capital performs on 21 percentage points more the average number of lead investments. The top amount of exits for fund were in 2019.
Among the most popular portfolio startups of the fund, we may highlight CStone Pharmaceuticals, MabSpace Biosciences, Gracell Biotechnologies. The fund has exact preference in a number of founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Diagnostics, Pharmaceutical.
The typical case for the fund is to invest in rounds with 6 participants. Despite the King Star Capital, startups are often financed by WuXi Healthcare Ventures, F-Prime Capital, Oriza Seed Capital (Oriza Yuandian). The meaningful sponsors for the fund in investment in the same round are Sequoia Capital China, Lilly Asia Ventures, YF Capital (Yunfeng Capital). In the next rounds fund is usually obtained by 6 Dimensions Capital.
Related Funds
| Fund Name | Location |
| Abacus Capital Group | New York, New York, United States |
| Caligan Partners | - |
| Chengdu Saide Gaoxin | Chengdu, China, Sichuan |
| Gaopeng Gong Chuang | China, Guangdong, Shenzhen |
| HEM ANGELS | India, Maharashtra, Mumbai |
| Heze Investment | China, Heze, Shandong |
| Hwa Create | Beijing, China, Haidian |
| Investment and Economic Development Bank of Rheinland-Pfalz | - |
| MMC Technology Ventures | - |
| Naftali Investments | - |
| NH Investimentos | Brazil, São Paulo, Sao Paulo |
| PTC Therapeutics | New Jersey, South Plainfield, United States |
| Quartz | - |
| REA Group | Australia, Melbourne, Victoria |
| Scenic Investments | - |
| Syllex | - |
| TED Beteiligungs GmbH | - |
| Vento Security Holdings | Massachusetts, Nantucket, United States |
| Yongda Investment Group | China, Shanghai |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Gracell Biotechnologies | $100M | 28 Oct 2020 | Gusu District, Jiangsu, China | ||
Gracell Biotechnologies | $85M | 25 Feb 2019 | Gusu District, Jiangsu, China | ||
MabSpace Biosciences | $40M | 11 May 2018 | China, Jiangsu | ||
CStone Pharmaceuticals | $260M | 09 May 2018 | China, Jiangsu | ||
Adagene | $50M | 27 Mar 2018 | China, Jiangsu |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Gracell Biotechnologies | $100M | 28 Oct 2020 | Gusu District, Jiangsu, China | ||
Gracell Biotechnologies | $85M | 25 Feb 2019 | Gusu District, Jiangsu, China | ||
MabSpace Biosciences | $40M | 11 May 2018 | China, Jiangsu | ||
CStone Pharmaceuticals | $260M | 09 May 2018 | China, Jiangsu | ||
Adagene | $50M | 27 Mar 2018 | China, Jiangsu |
